K. Noma

Effects of Ipragliflozin on Postprandial Glucose Metabolism and Gut Peptides in Type 2 Diabetes: A Pilot Study

H. Sakoda, M. Nakazato, H. Ueno, 2018, Diabetes Therapy.

Therapeutic potential of ghrelin treatment for unloading-induced muscle atrophy in mice.

K. Toshinai, M. Nakazato, K. Koshinaka, 2011, Biochemical and biophysical research communications.

Exploratory Trial of Intranasal Administration of Glucagon-Like Peptide-1 in Japanese Patients With Type 2 Diabetes

M. Nakazato, Tomomi Shiiya, M. Mizuta, 2014, Diabetes Care.

Telmisartan suppresses food intake in mice via the melanocortin pathway.

K. Toshinai, M. Nakazato, K. Koshinaka, 2011, Obesity research & clinical practice.

Fenofibrate ameliorates insulin resistance, hypertension and novel oxidative stress markers in patients with metabolic syndrome.

M. Nakazato, Tomomi Shiiya, M. Mizuta, 2011, Obesity research & clinical practice.

Pioglitazone attenuates fatty acid–induced oxidative stress and apoptosis in pancreatic β‐cells

M. Nakazato, M. Mizuta, H. Ueno, 2008, Diabetes, obesity & metabolism.

Glucagon-like peptide-1 and candesartan additively improve glucolipotoxicity in pancreatic β-cells.

M. Nakazato, M. Mizuta, Hong-wei Wang, 2011, Metabolism: clinical and experimental.

Telmisartan suppresses food intake in mice via the melanocortin pathway.

K. Toshinai, M. Nakazato, K. Koshinaka, 2011, Obesity research & clinical practice.